Yes, it's better to buy before SAMR approved. However, if it won't buyback would be the last thing on their mind. They said in the statement that they will be watching market conditions and stated covid and SAMR as two main risks. It seems they were handling covid quite well before, but SAMR is somewhat different and pretty much the only thing that can derail the company. I suspect they want to be sure before deploying cash.
Yes, it's better to buy before SAMR approved. However, if it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.84 |
Change
0.010(0.13%) |
Mkt cap ! $5.676B | |||
| Open | High | Low | Value | Volume |
| $7.80 | $7.90 | $7.78 | $14.54M | 1.854M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5507 | $7.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.88 | 14515 | 4 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |